From: Role of ultrasound, clinical and scintigraphyc parameters to predict malignancy in thyroid nodule
FNAC | Final Histology | Total | |
---|---|---|---|
Bethesda Category* | Benign | Malign | |
II | 24 (80%) | 6 (20%) | 30 (21.7%) |
III | 45 (93.8%) | 3 (6.2%) | 48 (34.8%) |
IV | 16 (47.1%) | 18 (52.9%) | 34 (24.6%) |
V | 05 (31.2%) | 11 (68.8%) | 16 (11.6%) |
VI | - | 10 (100%) | 10 (7.3%) |
Total | 90 | 48 | 138 (100%) |